GlassScriptPhysician profile
Spencer Sechler
NPI 1922557032
$4,420.80
in general payments reported to CMS, 2019-2025
12 companies · $805 in 2025
The $805 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2020: $98.24 · 2021: $455 · 2022: $826 · 2023: $660 · 2024: $869 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,134 · Gift: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,133.76 |
| Gift | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,081.67 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $937.84 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $786.51 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $409.71 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $385.79 | 2024-2025 | Xdemvy |
| Coopervision INC. | $323.61 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Biofinity Contact Lens |
| Visionary Optics LLC | $200.00 | 2024 | |
| Horizon Therapeutics Plc | $98.71 | 2022 | |
| Aerie Pharmaceuticals, INC. | $97.76 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $62.27 | 2019 | |
| Shire North American Group INC | $19.73 | 2019 | |
| Maculogix, INC. | $17.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Sechler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.